Relief Therapeutics Holding AG (RLFTF)

[J-Belfort]

"I’m gravely concerned," Javitt said, speaking to variants threatening to diminish vaccine efficacy. "We should certainly celebrate the strides that we’ve made in getting a baseline level of vaccination in the population but we can’t let our vigilance down for a second."

"We need to constantly be surveilling for these new variants and we need to be developing Covid therapeutics that will rescue people who get Covid even in the face of the vaccination programs."

- Dr. Jonathan Javitt, CEO of NRx and adjunct professor at Johns Hopkins School of Medicine, told Fox News.

https://www.foxnews.com/health/lag-covid-19-vaccine-boosters-variants-therapeutics


There is no shortage of bio companies with ill equipped management. I do not think RLF/NRX would fall into that group though. They are all well seasoned and veterans of big pharma and bio companies, they know the game and have a financial interest just like we do. Say what you want but these are guys I am invested with. I got JJ, I got Ram, I got GEM... Those are my business partners and they ALL bring an area of expertise to the table. I am still not convinced Ram doesn't have a list of company's to acquire and we are just getting started on the A's of it.

There is plenty of scientific literature with empirical evidence on peptide function in mammals. A wealth of those show the benefits of VIP specifically and appear to offer potentially new treatment for a wide array of ailments. Safety & Efficacy seem to be a given at this point. The results already have been speaking for themselves. RLF/NRX are doing this without some BP "sponsor" because they are all extremely well equipped with the nuances and kid gloves that are required with the US FDA.

Best,
JB

“The stock market is a device for transferring money from the impatient to the patient”
-Warren Buffett